We are live on ! Find out more
BCM

Bluefin Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
+30.05%
1 Year Est. Return
+18.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.19B
AUM Growth
+$411M
Cap. Flow
-$505M
Cap. Flow %
-42.57%
Top 10 Hldgs %
57.85%
Holding
553
New
134
Increased
94
Reduced
119
Closed
169

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 9.67%
2 Technology 5.28%
3 Financials 3.95%
4 Healthcare 1.98%
5 Communication Services 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
376
PUT
Apple
AAPL
$4.57T
-88,000
Closed -$450K
ABBV icon
377
CALL
AbbVie
ABBV
$435B
-10,000
Closed -$5K
ABBV icon
378
PUT
AbbVie
ABBV
$435B
-100,000
Closed -$1.55M
AMRN
379
CALL
Amarin Corp
AMRN
$303M
-114,195
Closed -$32K
AMRN
380
Amarin Corp
AMRN
$303M
-7,726
Closed -$618K
AMRN
381
PUT
Amarin Corp
AMRN
$303M
-16,325
Closed -$3.05M
AMT icon
382
American Tower
AMT
$80.4B
-1,000
Closed -$218K
AMZN icon
383
Amazon
AMZN
$2.96T
-15,000
Closed -$1.46M
OPTU
384
Optimum Communications Inc
OPTU
$301M
-20,000
Closed -$446K
AUPH icon
385
CALL
Aurinia Pharmaceuticals
AUPH
$2.04B
-72,000
Closed -$56K
BBWI icon
386
CALL
Bath & Body Works
BBWI
$4.1B
-24,740
Closed -$7K
BHC icon
387
Bausch Health
BHC
$2.34B
-23,290
Closed -$361K
BHC icon
388
PUT
Bausch Health
BHC
$2.34B
-100,000
Closed -$25K
BHP icon
389
BHP
BHP
$230B
-73,714
Closed -$2.41M
BMRN icon
390
CALL
BioMarin Pharmaceuticals
BMRN
$12.3B
-54,800
Closed -$16K
BMRN icon
391
PUT
BioMarin Pharmaceuticals
BMRN
$12.3B
-12,500
Closed -$32K
BMY icon
392
Bristol-Myers Squibb
BMY
$132B
-16,081
Closed -$962K
CBRL icon
393
CALL
Cracker Barrel
CBRL
$1.29B
-42,300
Closed -$4K
CCL icon
394
Carnival Corporation Ltd
CCL
$39.7B
-35,234
Closed -$528K
CHRS icon
395
Coherus Oncology
CHRS
$196M
-29,219
Closed -$474K
CHRS icon
396
PUT
Coherus Oncology
CHRS
$196M
-45,000
Closed -$307K
CMCSA icon
397
CALL
Comcast
CMCSA
$90B
-10,700
Closed -$17K
CSCO icon
398
PUT
Cisco
CSCO
$479B
-21,700
Closed -$33K
CVM icon
399
PUT
CEL-SCI Corp
CVM
$30.1M
-340
Closed -$17K
CVS icon
400
PUT
CVS Health
CVS
$122B
-10,400
Closed -$24K

Similar funds

Bluefin Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Bluefin Capital Management held 553 positions worth $1.19B, up 53% from $776M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Bluefin Capital Management withdrew a net $505M in Q2 2020, closing 169 positions and reducing 119 holdings. Its most notable exit was iPath Series B S&P 500 VIX Short-Term Futures ETN, an estimated $62.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 9.7% of assets, up from 5.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Bluefin Capital Management opened a new position in Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A worth $101M.

  • Bluefin Capital Management's largest Q2 2020 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 67,715 shares worth $101M.
  • Bluefin Capital Management added most to Alibaba in Q2 2020, an estimated $36.7M increase.
  • Bluefin Capital Management's biggest Q2 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $55.8M.
  • Bluefin Capital Management fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $62.6M.
  • Bluefin Capital Management's ten largest holdings make up 58% of its $1.19B portfolio in Q2 2020.
  • Bluefin Capital Management opened 134 new positions and closed 169 in Q2 2020.
  • Bluefin Capital Management's portfolio value rose 53% quarter-over-quarter to $1.19B.

Based on Bluefin Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.